Keros Therapeutics, Inc. · NASDAQ:KROS

Newton Charles W. sold 551 Keros Therapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Newton Charles W. (Director) sold 551 Keros Therapeutics, Inc. shares at an average US$10.85 for US$5,981 under a trading plan, leaving 11,563 shares. Filed Nov 19, 2026 (Form 4).

Sold
551 shares
Price
US$10.85 average (US$10.83 to US$11.05)
Value
US$5,981
Holding after
11,563 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale491US$10.8311,623Direct
Nov 17, 2026Common StockSale60US$11.0511,563Direct

Source

Download original · View original at SEC

Related